GABA-ergic neurotransmission in the nucleus of the solitary tract modulates cough in the cat

被引:12
|
作者
Kotmanova, Z. [1 ]
Simera, M. [1 ]
Veternik, M. [1 ]
Martvon, L. [1 ]
Misek, J. [1 ]
Jakus, J. [1 ]
Shen, T. Y. [2 ]
Musselwhite, M. N. [2 ]
Pitts, T. [3 ]
Bolser, D. C. [2 ]
Poliacek, I. [1 ]
机构
[1] Comenius Univ, Jessenius Fac Med Martin, Inst Med Biophys, Mala Hora 4, Martin 03601, Slovakia
[2] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA
[3] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA
关键词
Muscimol; Baclofen; Microinjection; Airway defense; Cough control; EXCITATORY AMINO-ACIDS; TRACHEOBRONCHIAL COUGH; MEDIATED NEUROTRANSMISSION; RESPIRATORY NEURONS; ANESTHETIZED CATS; SYNAPTIC INPUTS; REFLEX; RECEPTORS; GABA; RAT;
D O I
10.1016/j.resp.2018.02.009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
GABA, muscimol, and baclofen were microinjected into the rostral (rNTS) and caudal solitary tract nucleus (cNTS) in 24 anesthetized cats. Electromyograms (EMGs) of diaphragm (DIA) and abdominal muscles (ABD), blood pressure and esophageal pressure (EP) were recorded and analysed. Bilateral microinjections of 1 mM GABA (total 66 +/- 4 nl), 1 mM baclofen (64 +/- 4 nl) and unilateral microinjections of 0.5 mM muscimol (33 1 nl) in the rNTS significantly reduced cough number (CN), amplitudes of ABD EMGs, expiratory EP, and prolonged the duration of the cough inspiratory phase. GABA microinjections decreased the amplitudes of cough-related DIA EMGs and inspiratory EP; muscimol microinjections decreased the cough DIA EMG on the contralateral side. Only microinjections of GABA into the cNTS suppressed CN. In some cases, microinjections prolonged the inspiratory phase, lowered respiratory rate, changed the depth of breathing, and increased blood pressure and heart rate. Our results confirm that GABA-ergic inhibitory mechanisms in the rNTS can regulate coughing in the anesthetized cat.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 50 条
  • [1] Modulation of Cough Reflex by Gaba-Ergic Inhibition in Medullary Raphe of the Cat
    Martvon, Lukas
    Kotmanova, Zuzana
    Dobrolubov, Boris
    Babalova, Lucia
    Simera, Michal
    Veternik, Marcel
    Pitts, Teresa
    Jakus, Jan
    Poliacek, Ivan
    PHYSIOLOGICAL RESEARCH, 2020, 69 : S151 - S161
  • [2] Direct enhancement of GABA-ergic neurotransmission by ammonia
    Ha, JH
    Knauer, S
    Moody, E
    Jones, EA
    Basile, AS
    ADVANCES IN CIRRHOSIS, HYPERAMMONEMIA, AND HEPATIC ENCEPHALOPATHY, 1997, 420 : 85 - 94
  • [3] GABA-ERGIC MECHANISMS IN CENTRALLY CONTROLLED COUGH
    NOSALOVA, G
    VARONOS, D
    PAPADOPOULUDAIFOTI, Z
    PHYSIOLOGIA BOHEMOSLOVACA, 1985, 34 (03): : 269 - 270
  • [4] Ischemized brain protection by modulators of GABA-ergic neurotransmission
    Balasanyan, MG
    Topchyan, HV
    Kanayan, AS
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S261 - S262
  • [5] Colocalization of A(2a) but not A(1) adenosine receptors with GABA-ergic neurons in cardiopulmonary chemoreflex network in the caudal nucleus of the solitary tract
    Minic, Zeljka
    O'Leary, Donal S.
    Goshgarian, Harry G.
    Scislo, Tadeusz J.
    PHYSIOLOGICAL REPORTS, 2018, 6 (22):
  • [6] The involvement of ammonia with the mechanisms that enhance GABA-ergic neurotransmission in hepatic failure
    Jones, EA
    Basile, AS
    ADVANCES IN CIRRHOSIS, HYPERAMMONEMIA, AND HEPATIC ENCEPHALOPATHY, 1997, 420 : 75 - 83
  • [7] Does Ammonia Contribute to Increased GABA-ergic Neurotransmission in Liver Failure?
    E. Anthony Jones
    Anthony S. Basile
    Metabolic Brain Disease, 1998, 13 : 351 - 360
  • [8] Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?
    Jones, EA
    Basile, AS
    METABOLIC BRAIN DISEASE, 1998, 13 (04) : 351 - 360
  • [9] Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy
    Basile, AS
    Jones, EA
    HEPATOLOGY, 1997, 25 (06) : 1303 - 1305
  • [10] EVIDENCE FOR AN INTRASTRIATAL GABA-ERGIC INFLUENCE ON DOPAMINE NEURONS OF CAT
    BARTHOLINI, G
    STADLER, H
    NEUROPHARMACOLOGY, 1977, 16 (05) : 343 - 347